retatrutide doses clinical trial VisualAbstract: reduces body weight by 17.5% in patients with obesity How Retatrutide Dosing Is Studied

The early weeks weren't easy

Ipamorelins similarity to ghrelin suggests potential benefits in improving vasculature and collagen synthesis

Possible mechanism and current evidence

After a median follow-up of 104 weeks, treatment with tirzepatide was associated with a significant reduction in the risk of adjudicated death from cardiovascular causes or a worsening heart failure event (hazard ratio (HR) = 0.62

#Bioengineering #Organogenesis #MedicalResearch #SyntheticBiology To view or add a comment, sign in From MBoC: Arthur Beyder, Mayo Clinic, explores how sensory enteroendocrine cells integrate calcium and cAMP signaling to translate gut stimuli into hormonal and neural responses